← Archive

Built for Medicaid Children, Bypassed by Medicaid Plans: The MCO Contracting Gap That Most Investor Decks Skip

Serving Medicaid children is not the same as being paid by the organizations that insure them. The distinction shapes which companies can scale and which cannot.

Pediatric Health Dispatch | Deep Dispatch | June 26, 2026

The Managed Care Gap Nobody Names Out Loud

Here is a fact that most pediatric health tech market analyses elide: serving Medicaid children is not the same as being paid by the organizations that insure them.

MACPAC reported that roughly 37% of children had Medicaid or CHIP coverage in 2024; an AAP analysis using CMS data put the figure closer to 49%. Either way, public insurance is the dominant payer for American children. And within Medicaid, managed care is the dominant delivery mechanism: around 68% of Medicaid-enrolled children are in some form of comprehensive risk-based managed care, with MCOs receiving capitated payments from state agencies and then responsible for the health outcomes and healthcare costs of their members.

That structure ought to be a massive opportunity for pediatric digital health. If an MCO holds capitation for 400,000 children in a state, and a startup can demonstrably reduce avoidable hospitalizations, emergency department visits, and fragmented care for those children, the math should work. The problem is that the math rarely presents itself so cleanly, and the contracting pathway between a pediatric startup and a Medicaid MCO is neither short nor standardized.

The reality is that most pediatric digital health companies serve Medicaid children without being MCO-contracted at the plan level. They operate in one of several parallel tracks: fee-for-service billing to Medicaid through provider enrollment; school district contracts that sit entirely outside MCO administrative structures (Hazel Health's 20-million-student footprint is a district-contracted model, not an MCO-contracted one); employer benefit arrangements that cover commercially insured children; or grant and philanthropic funding that enables care access without a reimbursement mechanism. "Medicaid-serving" is an accurate and important claim. "MCO-contracted" is a materially different one, and the two should not be conflated in investor decks, market maps, or company positioning.

The gap matters most as companies try to scale. Fee-for-service Medicaid has rate adequacy problems, state-by-state variation, and no shared savings upside. School district contracts are fragile — dependent on district budgets, state funding formulas, and annual renewal cycles. Employer channels are structurally inappropriate for companies whose clinical mission centers on Medicaid families. Only direct MCO contracting, with a per-member per-month payment structure and risk-sharing upside, provides the financial architecture that makes a pediatric Medicaid company genuinely scalable.

The Three Walls

The structural barriers to MCO contracting in pediatrics are not mysterious, but they operate together in ways that make the challenge steeper than any one alone would suggest.

The first is what we might call the actuarial ceiling. MCO savings potential in pediatrics is concentrated in a small, identifiable population. CHOP's data put it plainly: 6.5% of Medicaid-enrolled children with serious chronic conditions account for around 40% of Medicaid spending on children's healthcare. For the other 93.5%, the PMPM cost is low, the clinical intervention opportunities are limited, and the savings pool is simply too thin to justify a plan's administrative and contracting investment in a new digital health partner. A startup that builds for the healthy-child majority of Medicaid members, rather than the high-complexity tail, will struggle to make the MCO math work regardless of how good its clinical model is.

The second barrier is procurement architecture. Medicaid managed care is not a national market. Each state runs its own managed care procurement, sets its own MCO contract requirements, defines its own quality incentive pools, and establishes its own supplemental payment and value-based arrangement rules. A company that successfully negotiates a strong risk-sharing contract with an MCO in Texas cannot replicate that contract in Florida or New York without going through each state's procurement machinery independently. The clinical model can scale; the contracting model cannot be copy-pasted. That means every new state entry requires a business development and regulatory strategy, not just a hiring and operational one — and MCO contract cycles typically run three to five years, with limited windows to enter or change terms.

The third barrier is payment rate adequacy. Even when an MCO wants to partner with a pediatric startup, the reimbursement floor is often inadequate for the care model the company is running. Medicaid base rates for pediatric primary care, behavioral health, and home-based services are systematically below what it costs to deliver complex care well. The pediatric home nursing market illustrates this starkly: Medicaid private-duty nursing rates of $17 to $38 per hour are permanently below the market rate of $35 to $65 or more, which is why agencies routinely decline or cannot fill complex pediatric cases. Technology cannot fix a rate mismatch, and value-based arrangements that layer on top of inadequate base payments start from a weak foundation. CMS's new decision-time requirements for Medicaid MCOs (72 hours for expedited prior auth, seven calendar days for standard requests, effective January 2026) address administrative friction but not the underlying rate problem.

Together, these three walls explain why pediatric VBC is real but thin. True downside-risk bearing in pediatrics exists in a small number of children's-hospital-led ACOs, provider-sponsored plans, and complex-care models. The broader category of "pediatric Medicaid companies" is mostly something else.

The Narrow Gate: What Threading It Actually Looks Like

The companies that have navigated MCO contracting in pediatrics didn't find a shortcut. They built through the narrow gate, and the gate has a specific shape.

The shape is: high-cost, medically complex children with special health care needs, contracted at the plan level in states with adequate CSHCN capitation rates, with demonstrated utilization reduction as the primary value proposition.

Imagine Pediatrics is the clearest example of a company that got the architecture right. Founded in 2022 as a virtual and in-home care platform for CSHCN, Imagine entered the market not by building a broad pediatric health tech product and then trying to retrofit MCO contracting, but by designing its operating model around the payer economics of medically complex Medicaid children from the start. Its February 2026 white paper reported more than 8,350 Safe Days at Home and more than 5,000 prevented ED and urgent care visits. The company's own reporting claims $65 million in health plan savings in 2024, a figure that, while company-published, is the kind of number that sustains MCO partnerships. A $67 million Series B in September 2025 (joined by Oak HC/FT, Optum Ventures, and Rubicon Founders) funded expansion into 12 states, and the company has said it is now entering the commercial plan market alongside its Medicaid base.

What Imagine understood that most pediatric startups do not is that the MCO relationship has to come before scale, not after. The company chose its initial state partner relationships, its quality metrics (Safe Days at Home, preventable-utilization reduction), and its target population (CSHCN) with the specific goal of generating a savings case that a Medicaid MCO could underwrite. That is a different design process than building a clinical model and then going to a payer with the results.

Nest Health is pursuing a variation on the same principle, with the added dimension of the whole-family household unit. Based in New Orleans, Nest contracts with Medicaid managed health plans to deliver in-home and virtual primary care, behavioral health, and social support across the family unit rather than only the pediatric patient. That household framing increases the PMPM value to the MCO by addressing the caregiver and sibling health needs that drive avoidable utilization in CSHCN families. Nest's November 2025 Series A close at $22.5 million, led by 8VC and Blue Venture Fund, funded expansion from Louisiana into Arizona — two states, not twenty, which reflects the state-by-state procurement reality rather than aspirational national scale.

Bluebird Kids Health, founded in 2024 and operating in South Florida, is the third model worth watching. It integrates behavioral health into pediatric primary care clinics in pediatric care deserts, serving children in communities where both commercial and Medicaid access is inadequate. Bluebird's $31.5 million Series A in March 2025, co-led by F-Prime and .406 Ventures, described value-based arrangements with Medicaid and commercial payers — though the specific structure of those MCO contracts is not publicly disclosed. The watch item is whether Bluebird's clinic-based model can generate the utilization data and quality metrics needed to move from "value-based arrangements" (a phrase that can mean many things) to actual shared-savings or capitated contracts with Florida's MCOs.

The contrast with companies that chose a different path is instructive. Brightline raised $212 million as a national virtual pediatric behavioral health platform, targeting commercial and employer channels with a predominantly commercially insured membership. After a September 2024 restructuring that shut down operations in 45 states, the company rebuilt around New York clinics and a five-state virtual footprint. The employer-commercial model gave Brightline a faster contracting path than Medicaid managed care — commercial payer and employer contracting is genuinely easier — but it also concentrated the company's market in the segment that covers fewer than half of U.S. children. A company that starts in Medicaid MCO contracting is operating in a harder environment, but it is building for the right population distribution.

US Pediatric Partners and Pediatric Associates Family of Companies represent a third approach: practice aggregation with a stated VBC trajectory. USPP has assembled more than 75 offices across five Mid-Atlantic and Southeast states since 2023, combining community pediatric practices with behavioral health acquisitions under a Webster Equity Partners PE platform. Pediatric Associates spans 260-plus locations and 1.5 million active patients across seven states. Both organizations use their scale to negotiate better rates with Medicaid MCOs, which is meaningful. But scale that produces better fee-for-service contracts is not the same as delegated-risk MCO contracting, and neither company has publicly disclosed the specific MCO contract structure that would distinguish them as true risk-bearing operators versus well-contracted practice networks.

What We're Watching

• ASPIRE state winners and operator composition. CMS's pediatric Medicaid innovation model is designed to add a federal layer of performance payments above state MCO contracts, giving risk-bearing pediatric operators a second revenue stream. When CMS announces the first ASPIRE state winners, the composition — how many states chose startup operators versus children's hospital systems — will be a signal about whether the federal government believes startups have matured enough for pediatric Medicaid risk delegation.
• UHC's pediatric prior-auth rollback and referral conversion. UnitedHealthcare's announcement in May 2026 to eliminate roughly two-thirds of prior authorization requirements for members under 18 — across cardiology, neurology, pulmonology, orthopedics, and imaging — is a real friction reduction for pediatric specialty operators. The question is whether reduced prior-auth friction converts into measurably faster contracting cycles or higher referral volumes for pediatric digital health companies in those service lines. A signal should be visible in company disclosures by early 2027.
• State MCO contract renewal calendars in Texas, Florida, and New York. The largest pediatric Medicaid managed care markets are in active or upcoming procurement cycles. Whether those procurements include pediatric digital health partners as eligible vendors, or restrict contracting to health system and traditional provider entities, will determine who has access to the largest pools of CSHCN lives. No single signal is more determinative for the next generation of pediatric Medicaid companies than the terms of these three state MCO contracts.

---